Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2021 08:30 ET | Source: Dyadic International, Inc.

Dyadic announces development of COVID-19 Vaccine in India

JUPITER, Fla., May 26, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...
March 29, 2021 08:30 ET | Source: Dyadic International, Inc.

UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial

Advancing Dyadic’s proprietary owned COVID-19 vaccine candidate, DYAI-100, towards first-in-human Phase 1 clinical trial Engaged CR2O, a contract research organization, to manage and support further...
March 23, 2021 09:00 ET | Source: Dyadic International, Inc.

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...
March 22, 2021 21:00 ET | Source: Dyadic International, Inc.

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...
March 22, 2021 08:30 ET | Source: Dyadic International, Inc.

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two...